Alternative non-antibody scaffolds for molecular recognition

Area of Science:

• Protein engineering
• Biotechnology
• Biopharmaceutical development

Background:

• The concept of engineering non-immunoglobulin proteins for binding functions has advanced significantly.
• Engineered protein scaffolds now achieve specificities and affinities comparable to antibodies.

Purpose of the Study:

• To review the evolution and current status of engineered protein scaffolds as alternatives to antibodies.
• To highlight promising scaffolds and their applications in research, biotechnology, and medicine.

Main Methods:

• Development of random mutagenesis libraries focused on surface-exposed regions.
• Selection of target-specific variants using techniques like phage display.
• Evaluation of scaffold properties including specificity, affinity, robustness, size, and expression.

Main Results:

• Several protein scaffolds, including protein A, lipocalins, fibronectin domains, ankyrin repeat domains, and thioredoxin, show broad applicability.
• These scaffolds offer practical advantages over antibodies, such as smaller size and ease of expression.
• Applications span research reagents, biotechnology separations, and biopharmaceuticals for cancer, autoimmune, and infectious diseases.

Conclusions:

• Engineered protein scaffolds are emerging as powerful tools in biotechnology and medicine.
• Despite challenges like immunogenicity and effector functions, their therapeutic and diagnostic potential is substantial.
• Scaffold-derived binding proteins are poised to play an increasingly important role in various scientific and medical fields.